Invention Grant
US09572792B2 Coumarin compounds as receptor modulators with therapeutic utility
有权
香豆素化合物作为具有治疗效用的受体调节剂
- Patent Title: Coumarin compounds as receptor modulators with therapeutic utility
- Patent Title (中): 香豆素化合物作为具有治疗效用的受体调节剂
-
Application No.: US14729969Application Date: 2015-06-03
-
Publication No.: US09572792B2Publication Date: 2017-02-21
- Inventor: Todd M. Heidelbaugh , John R. Cappiello , Phong X. Nguyen , Dario G. Gomez
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Barbara C. Potts
- Main IPC: A61K31/365
- IPC: A61K31/365 ; A61K31/366 ; A61K31/37 ; C07D311/16 ; C07D311/18 ; C07D405/12 ; A61K31/4025 ; A61K31/4433 ; A61K31/453 ; A61K31/501
Abstract:
The present invention relates to novel 2-oxo-2H-chromene-3-carboxamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
Public/Granted literature
- US20150265573A1 COUMARIN COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY Public/Granted day:2015-09-24
Information query
